POSEDEL RHEA J 4

What Happened

• Rhea J. Posedel, a director of Aehr Test Systems (AEHR), reported sales of 17,719 shares on April 22, 2026. The filing shows 17,115 shares sold at $100.00 each ($1,711,500) and 604 shares sold at $95.00 each ($57,380), for a combined proceeds of $1,768,880. These were reported as open-market or private sales (code S).

Key Details

• Transaction date(s) and prices: 2026-04-22 — 17,115 shares @ $100.00; 604 shares @ $95.00.
• Total shares sold: 17,719; total proceeds: $1,768,880.
• Shares owned after transaction: not specified in the Form 4 filing.
• Footnote: F1 — reported amounts include shares that are subject to unvested restricted stock units (RSUs).
• Filing timeliness: Form filed on 2026-04-22 (same date as the transactions), indicating a timely report.

Context

• This filing records sales (not purchases); sales are common for liquidity or tax reasons and do not by themselves indicate the director’s view of the company. The footnote that some shares are unvested RSUs means part of the reported position may not have been freely tradable at vesting.